NMS·Healthcare·$689M·#367 / 520 in Healthcare
ARVN Arvinas, Inc.
32HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY0
STABILITY40
VALUATION92
GOVERNANCE69
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-0.3%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
6 months
11
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
2.1%
98
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.6x
92
< 3x strong
Rule of 40
Growth rate plus operating margin
-45
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
7.8%
54
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-12.4%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ARVN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ARVN's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.